Home Antibody All anti-PIK3R1 antibodies
Also for PIK3R1 (NM_181523)
|This antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide selected from the N-terminal region starting with leucine at position 11 of human PI3KR1.|
||Lot dependent; please refer to CoA along with shipment
||WB: 1:50~100; IHC: 1: 10~50; ELISA: 1: 1,000;
|Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide.|
|This antibody is purified through a protein A column, followed by peptide affinity purification.
|Homo sapiens phosphoinositide-3-kinase, regulatory subunit 1 (alpha) (PIK3R1), transcript variant 1|
|AGM7; GRB1; p85; p85-ALPHA|
|Phosphatidylinositol 3-kinase phosphorylates the inositol ring of phosphatidylinositol at the 3-prime position. The enzyme comprises a 110 kD catalytic subunit and a regulatory subunit of either 85, 55, or 50 kD. This gene encodes the 85 kD regulatory subunit. Phosphatidylinositol 3-kinase plays an important role in the metabolic actions of insulin, and a mutation in this gene has been associated with insulin resistance.|
Delta-Notch Signaling Pathway
EGFR1 Signaling Pathway
Jak-STAT signaling pathway
Signaling by GPCR
TGF Beta Signaling Pathway
Toll-like receptor signaling pathway
* Shipping is in business days
* OriGene provides validated application data and protocol, with money back guarantee.
(LEFT)Western blot analysis of anti-PIK3R1 Antibody (N-term L11) Pab in CEM and Hela cell line lysates (35ug/lane). PIK3R1(arrow) was detected using the purified Pab (1:63 dilution). (RIGHT)Western blot analysis of anti-PI3KR1 Antibody (N-term L11) Pab in 293 cell line lysates transiently transfected with the PIK3R1 gene (3ug/lane). PI3KR1(arrow) was detected using the purified Pab (1:60 dilution).
Formalin-fixed and paraffin-embedded human skeletal muscle tissue reacted with PIK3R1 Antibody (N-term), which was peroxidase-conjugated to the secondary antibody, followed by DAB staining. This data demonstrates the use of this antibody for immunohistochemistry; clinical relevance has not been evaluated.